Literature DB >> 15672607

Monoclonal antibodies to the mouse p19(Arf) tumor suppressor protein.

David Bertwistle1, Frederique Zindy, Charles J Sherr, Martine F Roussel.   

Abstract

The Arf tumor suppressor protein inhibits cell proliferation through both p53-dependent and -independent mechanisms. Two rat monoclonal antibodies raised against a peptide corresponding to amino acids 54-75 of the mouse p19(Arf) protein reacted with the native protein expressed in mammalian cells. Neither antibody detected human or golden hamster Arf proteins. The two antibodies, both of IgG2b isotype, are directed to adjacent epitopes contained within residues 54-62 and 62-75, respectively, of the mouse p19(Arf) protein, and both were highly efficient in detecting p19(Arf) by immunoprecipitation, immunoblotting, and immunofluorescence. One antibody proved useful for immunohistochemical staining of p19(Arf) in fixed sections of mouse testes, revealing low levels of protein expression within the nucleoli of spermatogonia. This indicates that these antibodies should be useful in detecting the endogenous p(19Arf) protein at specific stages of mouse development and during early stages of tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15672607     DOI: 10.1089/hyb.2004.23.293

Source DB:  PubMed          Journal:  Hybrid Hybridomics        ISSN: 1536-8599


  19 in total

1.  Expression of Dmp1 in specific differentiated, nonproliferating cells and its regulation by E2Fs.

Authors:  A Mallakin; P Taneja; L A Matise; M C Willingham; K Inoue
Journal:  Oncogene       Date:  2006-07-31       Impact factor: 9.867

2.  Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function.

Authors:  Chandrashekhar Korgaonkar; Jussara Hagen; Van Tompkins; April A Frazier; Chantal Allamargot; Frederick W Quelle; Dawn E Quelle
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

3.  Small mitochondrial Arf (smArf) protein corrects p53-independent developmental defects of Arf tumor suppressor-deficient mice.

Authors:  Jolieke G van Oosterwijk; Chunliang Li; Xue Yang; Joseph T Opferman; Charles J Sherr
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-26       Impact factor: 11.205

4.  Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis.

Authors:  E M Michalak; E S Jansen; L Happo; M S Cragg; L Tai; G K Smyth; A Strasser; J M Adams; C L Scott
Journal:  Cell Death Differ       Date:  2009-01-16       Impact factor: 15.828

5.  Arf tumor suppressor and miR-205 regulate cell adhesion and formation of extraembryonic endoderm from pluripotent stem cells.

Authors:  Chunliang Li; David Finkelstein; Charles J Sherr
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-04       Impact factor: 11.205

6.  Rescue of key features of the p63-null epithelial phenotype by inactivation of Ink4a and Arf.

Authors:  Xiaohua Su; Min Soon Cho; Young-Jin Gi; Bernard A Ayanga; Charles J Sherr; Elsa R Flores
Journal:  EMBO J       Date:  2009-06-04       Impact factor: 11.598

7.  A non-tumor suppressor role for basal p19ARF in maintaining nucleolar structure and function.

Authors:  Anthony J Apicelli; Leonard B Maggi; Angela C Hirbe; Alexander P Miceli; Mary E Olanich; Crystal L Schulte-Winkeler; Anthony J Saporita; Michael Kuchenreuther; José Sanchez; Katherine Weilbaecher; Jason D Weber
Journal:  Mol Cell Biol       Date:  2007-12-10       Impact factor: 4.272

8.  Stage-specific Arf tumor suppression in Notch1-induced T-cell acute lymphoblastic leukemia.

Authors:  Emmanuel J Volanakis; Richard T Williams; Charles J Sherr
Journal:  Blood       Date:  2009-09-16       Impact factor: 22.113

9.  C/EBPbeta represses p53 to promote cell survival downstream of DNA damage independent of oncogenic Ras and p19(Arf).

Authors:  S J Ewing; S Zhu; F Zhu; J S House; R C Smart
Journal:  Cell Death Differ       Date:  2008-07-18       Impact factor: 15.828

10.  Distinct thresholds govern Myc's biological output in vivo.

Authors:  Daniel J Murphy; Melissa R Junttila; Laurent Pouyet; Anthony Karnezis; Ksenya Shchors; Duyen A Bui; Lamorna Brown-Swigart; Leisa Johnson; Gerard I Evan
Journal:  Cancer Cell       Date:  2008-12-09       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.